Literature DB >> 22800563

Vagal afferent modulation of spinal trigeminal neuronal responses to dural electrical stimulation in rats.

O A Lyubashina1, A Y Sokolov, S S Panteleev.   

Abstract

Vagus nerve stimulation (VNS) is an approved antiepileptic and antidepressant treatment, which has recently shown promise as a therapy for drug-resistant primary headaches. Specific neurobiological mechanisms underlying its anticephalgic action are not elucidated, partly because of the deficiency of research-related findings. The spinal trigeminal nucleus (STN) plays a prominent role in pathophysiology of headaches by modulating pain transmission from intracranial structures to higher centers of the brain. To determine whether vagal stimulation may affect trigeminovascular nociception, we investigated the effects of VNS on the STN neuronal activity in the animal model of headache. In anesthetized rats the spike activity of the STN neurons with convergent orofacial and meningeal inputs was monitored, and the changes in neuronal responses to electrical stimulation of the dura mater under preconditioning or under continuous electrical stimulation of the left cervical vagus nerve were studied. Preconditioning vagal afferent stimulation (200-ms train of pulses at 30 Hz applied before each dural stimulus) did not produce substantial changes in the STN spike activity. However, continuous VNS with frequency of 10 Hz in 48% of cases significantly suppressed trigeminal neuronal responses to dural electrical stimulation. In line with the decrease in evoked activity, the VNS-induced depression of ongoing neuronal firing was observed. Although the inhibitory effect was prevailing, 29.5% of STN neurons were facilitated by VNS, whereas 22.5% were unresponsive to the stimulation. These results provide an evidence of VNS-induced modulation of trigeminovascular nociception, and therefore contribute to a deeper understanding of neurophysiological mechanisms underlying effects of vagal stimulation in chronic drug-resistant headaches.
Copyright © 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22800563     DOI: 10.1016/j.neuroscience.2012.07.011

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  16 in total

Review 1.  Noninvasive vagus nerve stimulation in the management of cluster headache: clinical evidence and practical experience.

Authors:  Dagny Holle-Lee; Charly Gaul
Journal:  Ther Adv Neurol Disord       Date:  2016-03-02       Impact factor: 6.570

2.  Modulation of brainstem activity and connectivity by respiratory-gated auricular vagal afferent nerve stimulation in migraine patients.

Authors:  Ronald G Garcia; Richard L Lin; Jeungchan Lee; Jieun Kim; Riccardo Barbieri; Roberta Sclocco; Ajay D Wasan; Robert R Edwards; Bruce R Rosen; Nouchine Hadjikhani; Vitaly Napadow
Journal:  Pain       Date:  2017-08       Impact factor: 6.961

3.  Role of neurostimulation in migraine.

Authors:  L Grazzi; A Padovan; P Barbanti
Journal:  Neurol Sci       Date:  2015-05       Impact factor: 3.307

Review 4.  Devices for Episodic Migraine: Past, Present, and Future.

Authors:  David Moreno-Ajona; Jan Hoffmann; Simon Akerman
Journal:  Curr Pain Headache Rep       Date:  2022-02-11

Review 5.  Invasive and Non-invasive Electrical Pericranial Nerve Stimulation for the Treatment of Chronic Primary Headaches.

Authors:  Kevin D'Ostilio; Delphine Magis
Journal:  Curr Pain Headache Rep       Date:  2016-11

6.  Inhibitory effect of high-frequency greater occipital nerve electrical stimulation on trigeminovascular nociceptive processing in rats.

Authors:  Olga A Lyubashina; Sergey S Panteleev; Alexey Y Sokolov
Journal:  J Neural Transm (Vienna)       Date:  2016-09-27       Impact factor: 3.575

7.  Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study.

Authors:  Piero Barbanti; Licia Grazzi; Gabriella Egeo; Anna Maria Padovan; Eric Liebler; Gennaro Bussone
Journal:  J Headache Pain       Date:  2015-06-30       Impact factor: 7.277

8.  Treatment of chronic migraine with transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t-VNS): a randomized, monocentric clinical trial.

Authors:  Andreas Straube; J Ellrich; O Eren; B Blum; R Ruscheweyh
Journal:  J Headache Pain       Date:  2015-07-09       Impact factor: 7.277

Review 9.  Current Approaches to Neuromodulation in Primary Headaches: Focus on Vagal Nerve and Sphenopalatine Ganglion Stimulation.

Authors:  Francesca Puledda; Peter J Goadsby
Journal:  Curr Pain Headache Rep       Date:  2016-07

10.  Vagus nerve stimulation inhibits cortical spreading depression.

Authors:  Shih-Pin Chen; Ilknur Ay; Andreia Lopes de Morais; Tao Qin; Yi Zheng; Homa Sadeghian; Fumiaki Oka; Bruce Simon; Katharina Eikermann-Haerter; Cenk Ayata
Journal:  Pain       Date:  2016-04       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.